Literature DB >> 6767779

Heavy chain-specific suppression of immunoglobulin synthesis and secretion by lymphocytes from patients with selective IgA deficiency.

S A Schwartz.   

Abstract

A simple, solid-state immunofluorescent assay specific for the heavy chain of human immunoglobulins (Ig) was adapted for studying pokeweed mitogen- (PWM) stimulated Ig biosynthesis and secretion by peripheral blood lymphocytes (PBL) in vitro. PBL from patients with panhypogammaglobulinemia were noted to synthesize and secrete decreased amounts of all classes of immunoglobulin after polyclonal activation of B cells in vitro with PWM. PBL from 14 patients with selective deficiency of IgA were capable of synthesizing and secreting significant levels of IgG and IgM after culture with PWM; however, they did not produce appreciable amounts of IgA. Thus, B lymphocyte differentiation in vitro parallels the clinical status. Several different immunoregulatory phenomena were observed when PBL from patients with selective IgA deficiency were co-cultivated with cells from healthy donors. Most notable was the specific suppression of IgA synthesis and secretion seen in 8 of 14 patients studied, although other modulatory effects including enhancement and suppression of all Ig classes were also observed. These results suggest that the pathologic basis of selective IgA deficiency may be heterogeneous and support a model for the role of Ig class-specific suppressor cells in the pathogenesis of some cases of selective IgA deficiency.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6767779

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Selective IgA deficiency: analysis of Ig production in vitro.

Authors:  T Inoue; H Okubo; J Kudo; T Ikuta; K Hachimine; R Shibata; O Yoshinari; K Fukada; T Yanase
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

2.  Isotype regulation of antibody production: T-cell hybrids can be selectively induced to produce IgG1 and IgG2 subclass-specific suppressive immunoglobulin-binding factors.

Authors:  I Löwy; C Brezin; C Neauport-Sautes; J Theze; W H Fridman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

3.  Disorders of regulatory T cells in patients with selective IgA deficiency and its relationship to associated autoimmune phenomena.

Authors:  E G De la Concha; J L Subiza; G Fontán; D Pascual-Salcedo; J Sequí; A Bootello
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

4.  Lymphocyte subpopulations in primary immunodeficiency disorders.

Authors:  S Gupta
Journal:  Indian J Pediatr       Date:  1982 May-Jun       Impact factor: 1.967

5.  Analysis of IgG subclass production in cell cultures from IgA deficient patients and in normal controls as a function of age.

Authors:  G Luzi; H Kubagawa; M J Crain; M D Cooper
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

6.  Immunological study of IgA deficiency during anticonvulsant therapy in epileptic patients.

Authors:  H Matsuoka; J Okada; T Takahashi; M Matsuoka; C Sato; S Torii
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

7.  A human soluble suppressor factor affecting lymphocyte responses in vitro.

Authors:  L Shou; S A Schwartz; R A Good; R Peng; C L Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

8.  Pokeweed mitogen and Staphylococcus aureus Cowan I induced immunoglobulin A synthesis by lymphocytes of IgA deficient blood donors.

Authors:  K Oen; M L Schroeder; D Krzekotowska
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

9.  In vitro studies on the mechanism of increased serum IgM levels in primary biliary cirrhosis.

Authors:  K T Nouri-Aria; J E Hegarty; J Neuberger; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

10.  Immunoregulation of immunoglobulin production in normal infants and children.

Authors:  K T Nouri-Aria; A Lobo-Yeo; D Vergani; G Mieli-Vergani; A P Mowat; A L Eddleston
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.